Literature DB >> 12011075

Hyaluronan binding properties of a CD44 chimera containing the link module of TSG-6.

Jayne Lesley1, Nicole M English, István Gál, Katalin Mikecz, Anthony J Day, Robert Hyman.   

Abstract

CD44, a cell-surface receptor for the extracellular matrix glycosaminoglycan hyaluronan, can mediate leukocyte rolling on hyaluronan substrates and has been implicated in leukocyte migration to sites of inflammation. CD44-mediated binding to hyaluronan is of low affinity, and effective cell/matrix interaction depends on multiple interactions with the multivalent ligand. We replaced the Link module of CD44 with the homologous region of TSG-6, a hyaluronan-binding protein secreted in response to inflammation whose Link module has a higher affinity for ligand. Monoclonal antibodies raised against the CD44/TSG-6 chimera recognized recombinant human TSG-6 and native mouse TSG-6 and blocked hyaluronan binding to these proteins. Cells expressing the CD44/TSG-6 molecule bound hyaluronan with higher avidity than cells expressing CD44. This resulted in changes in the hyaluronan binding properties characteristic of cells expressing CD44 such as requirements for threshold levels of receptor expression and for hyaluronan of high molecular mass. In parallel plate flow assays used to model leukocyte rolling, cells expressing CD44/TSG-6 failed to roll on hyaluronan. Instead, they stuck and remained "tethered" to the substrate under fluid flow. This result argues that the low affinity of CD44 for its ligand is important for rolling, an early phase of leukocyte extravasation from the blood.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12011075     DOI: 10.1074/jbc.M201068200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  TSG-6 potentiates the antitissue kallikrein activity of inter-alpha-inhibitor through bikunin release.

Authors:  Rosanna Forteza; Susana M Casalino-Matsuda; Maria Elena Monzon; Erik Fries; Marilyn S Rugg; Caroline M Milner; Anthony J Day
Journal:  Am J Respir Cell Mol Biol       Date:  2006-07-27       Impact factor: 6.914

2.  TSG-6 protein, a negative regulator of inflammatory arthritis, forms a ternary complex with murine mast cell tryptases and heparin.

Authors:  Gyorgy Nagyeri; Marianna Radacs; Sheida Ghassemi-Nejad; Beata Tryniszewska; Katalin Olasz; Gabor Hutas; Zsuzsa Gyorfy; Vincent C Hascall; Tibor T Glant; Katalin Mikecz
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

Review 3.  Fibroblasts and myofibroblasts in renal fibrosis.

Authors:  Soma Meran; Robert Steadman
Journal:  Int J Exp Pathol       Date:  2011-02-28       Impact factor: 1.925

4.  CD44v6 coordinates tumor matrix-triggered motility and apoptosis resistance.

Authors:  Thorsten Jung; Wolfgang Gross; Margot Zöller
Journal:  J Biol Chem       Date:  2011-03-03       Impact factor: 5.157

5.  Interactions of peptide mimics of hyaluronic acid with the receptor for hyaluronan mediated motility (RHAMM).

Authors:  Michael R Ziebell; Glenn D Prestwich
Journal:  J Comput Aided Mol Des       Date:  2004-10       Impact factor: 3.686

6.  Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma.

Authors:  Thomas Winder; Yan Ning; Dongyun Yang; Wu Zhang; Derek G Power; Pierre Bohanes; Armin Gerger; Peter M Wilson; Georg Lurje; Laura H Tang; Manish Shah; Heinz-Josef Lenz
Journal:  Int J Cancer       Date:  2011-02-11       Impact factor: 7.396

Review 7.  CD44 in cancer progression: adhesion, migration and growth regulation.

Authors:  R Marhaba; M Zöller
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

8.  TSG-6 transfers proteins between glycosaminoglycans via a Ser28-mediated covalent catalytic mechanism.

Authors:  Kristian W Sanggaard; Carsten S Sonne-Schmidt; Toke P Krogager; Torsten Kristensen; Hans-Georg Wisniewski; Ida B Thøgersen; Jan J Enghild
Journal:  J Biol Chem       Date:  2008-09-26       Impact factor: 5.157

9.  Antitumor therapy mediated by 5-fluorocytosine and a recombinant fusion protein containing TSG-6 hyaluronan binding domain and yeast cytosine deaminase.

Authors:  Joshua I Park; Limin Cao; Virginia M Platt; Zhaohua Huang; Robert A Stull; Edward E Dy; Jeffrey J Sperinde; Jennifer S Yokoyama; Francis C Szoka
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

10.  miRNA-34a inhibits cell adhesion by targeting CD44 in human renal epithelial cells: implications for renal stone disease.

Authors:  Bohan Wang; Gaofei He; Gang Xu; Jiaming Wen; Xiao Yu
Journal:  Urolithiasis       Date:  2019-09-10       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.